Erratum. A Novel CCK-8/GLP-1 Hybrid Peptide Exhibiting Prominent Insulinotropic, Glucose-Lowering, and Satiety Actions With Significant Therapeutic Potential in High-Fat–Fed Mice. Diabetes 2015;64:2996—3009
- Nigel Irwin,
- Varun Pathak and
- Peter R. Flatt
In the article cited above, there is a small error in the amino acid sequence of the hybrid peptide presented in Supplementary Table 1. The correct amino acid sequence is listed below.
The online version reflects this change.
View this table:
Supplementary Table 1
Amino acid sequence of (pGlu-Gln)-CCK-8, exendin-4 and the novel (pGlu-Gln)-CCK-8/exendin-4 hybrid molecule
- © 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
In this Issue
April 2016, 65(4)
Erratum. A Novel CCK-8/GLP-1 Hybrid Peptide Exhibiting Prominent Insulinotropic, Glucose-Lowering, and Satiety Actions With Significant Therapeutic Potential in High-Fat–Fed Mice. Diabetes 2015;64:2996—3009
